tiprankstipranks
Advertisement
Advertisement
Botanix issues investor update with detailed disclaimers and risk caveats
PremiumCompany AnnouncementsBotanix issues investor update with detailed disclaimers and risk caveats
1M ago
Botanix builds Sofdra momentum, fortifies balance sheet and supply chain
Premium
Company Announcements
Botanix builds Sofdra momentum, fortifies balance sheet and supply chain
1M ago
Botanix Director Granted Options Linked to Share Placement
Premium
Company Announcements
Botanix Director Granted Options Linked to Share Placement
1M ago
Botanix Secures A$45m Through Share Plan and Placement to Fund Sofdra Rollout
PremiumCompany AnnouncementsBotanix Secures A$45m Through Share Plan and Placement to Fund Sofdra Rollout
2M ago
Botanix options lapse, trimming potential share dilution
Premium
Company Announcements
Botanix options lapse, trimming potential share dilution
2M ago
Botanix Pharmaceuticals: Sofdra Supply Chain Strength, Cost Reduction, and Patent Longevity Support Buy Rating and A$1.00 Target
Premium
Ratings
Botanix Pharmaceuticals: Sofdra Supply Chain Strength, Cost Reduction, and Patent Longevity Support Buy Rating and A$1.00 Target
2M ago
Botanix Wins Shareholder Backing for A$45m Capital Raising to Fund Sofdra Rollout
PremiumCompany AnnouncementsBotanix Wins Shareholder Backing for A$45m Capital Raising to Fund Sofdra Rollout
2M ago
Botanix Defers API Purchases and Moves to De-Risk Sofdra Supply Chain
Premium
Company Announcements
Botanix Defers API Purchases and Moves to De-Risk Sofdra Supply Chain
2M ago
Botanix Showcases FDA-Approved Hyperhidrosis Drug at Euroz Hartleys Conference
Premium
Company Announcements
Botanix Showcases FDA-Approved Hyperhidrosis Drug at Euroz Hartleys Conference
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100